Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates

Launched by UNIVERSITY OF CALGARY · Mar 21, 2018

Keywords

ClinConnect Summary

This clinical trial is looking at how the location where a special type of IV line, called a peripherally inserted central catheter (PICC), is placed affects the chances of any problems that might require the line to be removed in newborns. The study is being conducted in the neonatal intensive care unit (NICU) at Foothills Medical Centre and Alberta Children's Hospital. Researchers want to understand if certain insertion sites are safer than others for these tiny patients, who are often very fragile.

To be part of this study, babies must be admitted to the NICU and need a PICC line for their care. They can be from any gestational age, meaning they can be born prematurely or at full term. However, babies with infections at the insertion site or certain skin conditions, as well as those with major genetic issues, will not be included. If your baby qualifies, they can participate in this important research aimed at improving care for newborns needing this type of catheter.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Neonates of all gestational ages admitted to Foothills Medical Centre and Alberta Children's Hospital Neonatal Intensive Care Unit (NICU)
• • 2. Peripherally inserted central venous catheter (PICC) line insertion planned as part of NICU care
• • 3. Venous access available in both upper(above umbilicus) and lower body
• Exclusion Criteria:
• • 1. Local infection at potential site of insertion
• • 2. Hemangioma, lymphangioma or malformations in the region of insertion
• • 3. Major chromosomal anomalies